CenterStar Asset Management’s AstraZeneca AZN Stock Holding History

CenterStar Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,200	Closed	-$631K	–	265
2026 Q1	$631K	Buy	3,200 +1,100	+52%	+$212K	0.08%	279
2025 Q4	$386K	Sell	2,100 -700	-25%	-$123K	0.11%	191
2025 Q3	$430K	Buy	+2,800	New	+$424K	0.09%	189
2024 Q4	–	Sell	-2,950	Closed	-$460K	–	245
2024 Q3	$460K	Buy	+2,950	New	+$476K	0.09%	176
2023 Q1	–	Hold	0	–	-$768	–	195
2022 Q4	–	Hold	0	–	–	–	85
2022 Q3	–	Hold	0	–	–	–	231
2022 Q2	–	Hold	0	–	–	–	31
2022 Q1	–	Hold	0	–	–	–	87
2021 Q3	–	Hold	0	–	-$3.31M	–	676
2021 Q2	–	Hold	0	–	–	–	53
2021 Q1	–	Hold	0	–	–	–	164
2020 Q1	–	Hold	0	–	-$45K	–	765
2019 Q4	–	Hold	0	–	–	–	208
2019 Q3	–	Hold	0	–	–	–	205

Other funds holding AZN

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CenterStar Asset Management's AZN Position: Q4 2025 in Review

CenterStar Asset Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 3,340 shares — an estimated $586K sold.

CenterStar Asset Management first reported a position in AZN in Q1 2025 and held it in 2 quarters. The position peaked at $512K in Q3 2025. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

CenterStar Asset Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
CenterStar Asset Management sold 3,340 AstraZeneca shares in Q4 2025, an estimated $586K.
CenterStar Asset Management first reported a position in AstraZeneca in Q1 2025 and held it in 2 quarters.
CenterStar Asset Management's AstraZeneca position peaked at $512K in Q3 2025.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on CenterStar Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.